145 related articles for article (PubMed ID: 30549402)
1. Is the SYNTAX Score II applicable in all percutaneous coronary intervention patients?
Gao G; Zhao Y; Zhang D; He Y; Song C; Zhu C; Guan C; Xu B; Yin D; Dou K
Catheter Cardiovasc Interv; 2019 Feb; 93(S1):779-786. PubMed ID: 30549402
[TBL] [Abstract][Full Text] [Related]
2. Validation and comparison of the long-term prognostic capability of the SYNTAX score-II among 1,528 consecutive patients who underwent left main percutaneous coronary intervention.
Xu B; Généreux P; Yang Y; Leon MB; Xu L; Qiao S; Wu Y; Yan H; Chen J; Zhao Y; Zhao Y; Palmerini T; Stone GW; Gao R
JACC Cardiovasc Interv; 2014 Oct; 7(10):1128-37. PubMed ID: 25240551
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of the SYNTAX score II to validate 2-year outcomes in patients with complex coronary artery disease undergoing percutaneous coronary intervention: A large single-center study.
Song Y; Gao Z; Tang X; Ma Y; Jiang P; Xu J; Yao Y; Zhao X; Qiao S; Yang Y; Gao R; Xu B; Yuan J
Catheter Cardiovasc Interv; 2018 Jul; 92(1):40-47. PubMed ID: 28895284
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the prognostic value of SYNTAX score and clinical SYNTAX score on outcomes of Chinese patients underwent percutaneous coronary intervention.
Li XQ; Yin C; Li XL; Wu WL; Cui K
BMC Cardiovasc Disord; 2021 Jul; 21(1):334. PubMed ID: 34233618
[TBL] [Abstract][Full Text] [Related]
5. The anatomic- and clinical-based NERS (new risk stratification) score II to predict clinical outcomes after stenting unprotected left main coronary artery disease: results from a multicenter, prospective, registry study.
Chen SL; Han YL; Zhang YJ; Ye F; Liu HW; Zhang JJ; Xu B; Jiang TM; Zhou YJ; Lv SZ
JACC Cardiovasc Interv; 2013 Dec; 6(12):1233-41. PubMed ID: 24239199
[TBL] [Abstract][Full Text] [Related]
6. Prediction of long-term patient outcome after contemporary left main stenting using the SYNTAX and SYNTAX II scores: A comparative analysis from the FAIL-II multicenter registry (failure in left main study with 2nd generation stents-Cardiogroup III study).
Cerrato E; Barbero U; Quadri G; Ryan N; D'Ascenzo F; Tomassini F; Quirós A; Bellucca S; Conrotto F; Ugo F; Kawamoto H; Rolfo C; Pavani M; Mejia-Renteria H; Gili S; Iannaccone M; Debenedictis M; Baldassarre D; Biondi-Zoccai G; Colombo A; Varbella F; Escaned J
Catheter Cardiovasc Interv; 2020 Jul; 96(1):E17-E26. PubMed ID: 31478334
[TBL] [Abstract][Full Text] [Related]
7. Global risk classification and clinical SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) score in patients undergoing percutaneous or surgical left main revascularization.
Capodanno D; Caggegi A; Miano M; Cincotta G; Dipasqua F; Giacchi G; Capranzano P; Ussia G; Di Salvo ME; La Manna A; Tamburino C
JACC Cardiovasc Interv; 2011 Mar; 4(3):287-97. PubMed ID: 21435606
[TBL] [Abstract][Full Text] [Related]
8. Objectifying the impact of incomplete revascularization by repeat angiographic risk assessment with the residual SYNTAX score after left main coronary artery percutaneous coronary intervention.
Capodanno D; Chisari A; Giacoppo D; Bonura S; Lavanco V; Capranzano P; Caggegi A; Ministeri M; Tamburino C
Catheter Cardiovasc Interv; 2013 Sep; 82(3):333-40. PubMed ID: 22936604
[TBL] [Abstract][Full Text] [Related]
9. SYNTAX Score-II Predicts Long-Term Mortality in Patients Who Underwent Left Main Percutaneous Coronary Intervention Treated With Second-Generation Drug-Eluting Stents.
He J; Zhao H; Yu X; Li Q; Lv S; Chen F; Jiang T
Int Heart J; 2017 May; 58(3):344-350. PubMed ID: 28539567
[TBL] [Abstract][Full Text] [Related]
10. Residual SYNTAX score after PCI for triple vessel coronary artery disease: quantifying the adverse effect of incomplete revascularisation.
Malkin CJ; George V; Ghobrial MS; Krishnan A; Siotia A; Raina T; Morton AC; Gunn J
EuroIntervention; 2013 Mar; 8(11):1286-95. PubMed ID: 23538157
[TBL] [Abstract][Full Text] [Related]
11. Individual Long-Term Mortality Prediction Following Either Coronary Stenting or Bypass Surgery in Patients With Multivessel and/or Unprotected Left Main Disease: An External Validation of the SYNTAX Score II Model in the 1,480 Patients of the BEST and PRECOMBAT Randomized Controlled Trials.
Sotomi Y; Cavalcante R; van Klaveren D; Ahn JM; Lee CW; de Winter RJ; Wykrzykowska JJ; Onuma Y; Steyerberg EW; Park SJ; Serruys PW
JACC Cardiovasc Interv; 2016 Aug; 9(15):1564-72. PubMed ID: 27491605
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of the SYNTAX score II to predict 1-year outcome in patients with primary percutaneous coronary intervention.
Wang G; Wang C; Zhang Y; Wang P; Ran C; Zhao L; Han L
Coron Artery Dis; 2016 Sep; 27(6):483-9. PubMed ID: 27171362
[TBL] [Abstract][Full Text] [Related]
13. Comparison of long-term prognostic value of baseline SYNTAX and clinical SYNTAX scores in ST-segment elevation myocardial infarction patients with multivessel disease.
Onuk T; Güngör B; İpek G; Karataş MB; Çanga Y; Akyüz Ş; Haci R; Karadeniz FÖ; Sungur A; Kaşikçioğlu H; Çam N
Coron Artery Dis; 2016 Jun; 27(4):311-8. PubMed ID: 26945185
[TBL] [Abstract][Full Text] [Related]
14. Integrating the residual SYNTAX score to improve the predictive ability of the age, creatinine, and ejection fraction (ACEF) score for cardiac mortality in percutaneous coronary intervention patients.
Gao G; Zhang D; Song C; Xu H; Yin D; Guan C; Yang Y; Xu B; Dou K
Catheter Cardiovasc Interv; 2020 Feb; 95 Suppl 1():534-541. PubMed ID: 31876352
[TBL] [Abstract][Full Text] [Related]
15. Long-term prognostic value of risk scores after drug-eluting stent implantation for unprotected left main coronary artery: A pooled analysis of the ISAR-LEFT-MAIN and ISAR-LEFT-MAIN 2 randomized clinical trials.
Xhepa E; Tada T; Kufner S; Ndrepepa G; Byrne RA; Kreutzer J; Ibrahim T; Tiroch K; Valgimigli M; Tölg R; Cassese S; Fusaro M; Schunkert H; Laugwitz KL; Mehilli J; Kastrati A
Catheter Cardiovasc Interv; 2017 Jan; 89(1):1-10. PubMed ID: 27515100
[TBL] [Abstract][Full Text] [Related]
16. Predicting 3-year mortality after percutaneous coronary intervention: updated logistic clinical SYNTAX score based on patient-level data from 7 contemporary stent trials.
Iqbal J; Vergouwe Y; Bourantas CV; van Klaveren D; Zhang YJ; Campos CM; García-García HM; Morel MA; Valgimigli M; Windecker S; Steyerberg EW; Serruys PW
JACC Cardiovasc Interv; 2014 May; 7(5):464-70. PubMed ID: 24852801
[TBL] [Abstract][Full Text] [Related]
17. Impact of 3-dimensional bifurcation angle on 5-year outcome of patients after percutaneous coronary intervention for left main coronary artery disease: a substudy of the SYNTAX trial (synergy between percutaneous coronary intervention with taxus and cardiac surgery).
Girasis C; Farooq V; Diletti R; Muramatsu T; Bourantas CV; Onuma Y; Holmes DR; Feldman TE; Morel MA; van Es GA; Dawkins KD; Morice MC; Serruys PW
JACC Cardiovasc Interv; 2013 Dec; 6(12):1250-60. PubMed ID: 24355115
[TBL] [Abstract][Full Text] [Related]
18. Comparison of syntax score and syntax score II to predict "no reflow phenomenon" in patients with ST-segment elevation myocardial infarction.
Yesin M; Çağdaş M; Kalçık M; Uluganyan M; Efe SÇ; Rencüzoğulları İ; Karabağ Y; Gürsoy MO; Karakoyun S
Int J Cardiovasc Imaging; 2017 Dec; 33(12):1883-1889. PubMed ID: 28664479
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of the SYNTAX score and SYNTAX score II in patients with myocardial infarction treated with percutaneous coronary intervention.
Di Maio M; Esposito L; Silverio A; Bellino M; Cancro FP; De Luca G; Di Muro FM; Vassallo MG; Vecchione C; Galasso G
Catheter Cardiovasc Interv; 2023 Nov; 102(5):779-787. PubMed ID: 37702117
[TBL] [Abstract][Full Text] [Related]
20. Early predictors of severe left main and/or three-vessel disease in patients with non-ST-segment elevation myocardial infarction: A dual-center retrospective study.
Huang B; Han X; Huang Y; Chen D; Xie P; Chen S
Ann Noninvasive Electrocardiol; 2024 May; 29(3):e13120. PubMed ID: 38706219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
